“…Topical therapies Several new topical drugs have been recently tested for OLP treatment including thalidomide (Wu et al , 2010), imiquimod (Gencoglan et al , 2011), hyaluronic acid (Nolan et al , 2009), sirolimus (rapamycin) (Soria et al , 2009), intralesional BCG‐PSN (Xiong et al , 2009), and pimecrolimus (McCaughey et al , 2011; Passeron et al , 2007; Swift et al , 2005; Volz et al , 2008). All but sirolimus, imiquimod, and intralesional BCG‐PSN have been tested in placebo‐controlled RCTs showing some benefits, but only pimecrolimus was tested in more than one study (Table 7).…”